About myTomorrows
myTomorrows is a company based in Amsterdam (Netherlands) founded in 2012 by Ronald Brus. myTomorrows has raised $51.3 million across 5 funding rounds from investors including Balderton Capital, EQT Ventures and Octopus Ventures. myTomorrows operates in a competitive market with competitors including Evidation, Antidote, Dyania Health, SubjectWell and Clara Health, among others.
- Headquarter Amsterdam, Netherlands
- Founders Ronald Brus
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website mytomorrows.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$51.3M (USD)
in 5 rounds
- Latest Funding Round$29M (USD), Series C
Nov 2025
- InvestorsBalderton Capital
& 4 more
Funding Insights of myTomorrows
myTomorrows has successfully raised a total of $51.3M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $29 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $51.3M
- Total Rounds 5
- Last Round Series C — $29M
- First Round $3.8M
(Jun 2012)
- Investors Count 5
All 5 funding rounds of myTomorrows with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $29M | Series C | – | – | |
| Jan 2017 | $10.69M | Series B | – | EQT Ventures, Octopus Ventures | |
| Nov 2014 | $5.61M | Series A | – | Balderton Capital, Sofinnova Investments | – |
| Feb 2014 | $2.2M | Seed | – | – | – |
| Jun 2012 | $3.8M | Angel Round | – | – | – |
5 investors in total: 5 institutional.
Investors in myTomorrows
myTomorrows has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Balderton Capital, EQT Ventures and Octopus Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in technology and innovation sectors. | – | eqtventures.com | - | |
Venture capital investment and support for founders in technology and health sectors. | – | octopusventures.com | - | |
Multistage venture capital investments are focused on technology sectors. | 2000 | balderton.com | London, United Kingdom | |
Biotech funding, drug development support, and investment in life sciences. | – | sofinnova.com | - | |
Private equity investments are directed toward the healthcare sector. | – | avego.com | - |
Investor details for myTomorrows
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of myTomorrows
24 people are tracked at myTomorrows (7 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
Ronald Brus | Co-Founder & CEO | Leadership |
Michel Van Harten | Co-CEO | Leadership |
Vanessa Lemarié | Chief Operating Officer | Leadership |
Sander Cranen | Director Quality Assurance | Leadership |
Daniele Tagliente | Director Regulatory Affairs & Pharmacovigilance | Leadership |
Jytte van Huijstee | Director Clinical Trial Operations | Leadership |
Roos Takken | Head Of People | Leadership |
Hatice Gurboyoglu | Regulatory Affairs Manager | Team |
Janiek Meppelink | General Counsel | Team |
Mar Soto Ruiz de la Torre | Program Manager | Team |
Lauren Hall | Pharmacovigilance Manager | Team |
Romina Dibra | Senior EAP Site Manager | Team |
Sacha Evans | Office Manager | Team |
Courtney Cox | Senior Recruiter | Team |
Calinda Dingenouts | Manager Regulatory Affairs & Pharmacovigilance | Team |
Paris Asif | Program Manager: Clinical Trial Operations | Team |
Giulia de Conti | Expanded Access Program Management Lead | Team |
Anna M Czok | Senior Program And Site Manager | Team |
Ronald Plasterk | CSO | Team |
Alexander Diamandidis | Qualified Person & GMP Consultant | Team |
4 more people are available in the full profile.
Complete people profiles for myTomorrows
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of myTomorrows
3 dated milestones of myTomorrows across 13 years, from founding to its latest funding, stage changes and deals.
- Founded myTomorrows is founded.
- Funding First funding round of $3.8M.
- Funding Latest funding round, Series C, of $29.0M.
Competitors of myTomorrows
myTomorrows operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evidation, Antidote, Dyania Health, SubjectWell and Clara Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evidation.com | 2012 | Menlo Park, United States | $259.16M | 196 | Real-world health data is provided for research and decisions. | |
| antidote.me | 2008 | London, United Kingdom | $52M | 39 | Provider of search engine tool for patients to explore, understand and access clinical trials. | |
| dyaniahealth.com | 2019 | Sacramento, United States | $15.3M | – | Patients for clinical trials are identified through a dedicated platform. | |
| subjectwell.com | 2012 | Austin, United States | $46.8M | – | Clinical trials marketplace for patient recruitment solutions is provided. | |
| clarahealth.com | 2015 | Boston, United States | $18.19M | 36 | Clinical trials are matched to patients via an online platform. | |
| belong.co | 2014 | Bengaluru, India | $15M | 1 | AI-enabled platform sources candidates for inclusive employment of disabled individuals. | |
| jumohealth.com | 2009 | New Haven, United States | $12.53M | 3 | Jumo Health is focused on improving clinical trial patient experiences. | |
| trialbee.com | 2010 | Malmo, Sweden | $21.13M | – | Cloud-based clinical trial recruitment solutions are provided for pharmaceutical companies. |
Detailed competitors of myTomorrows
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of myTomorrows
The website of myTomorrows (mytomorrows.com) receives about 25.5K visits a month and ranks #1,200,128 among all websites worldwide, #1,509 in Biotechnology and Pharmaceuticals.
- Monthly visits25.5K
▲ 29% vs previous month
- Unique visitors8.9K
per month
- Global rank#1,200,128
among all websites
- Category rank#1,509
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit2.6
- Average visit1 min 02 sec
- DevicesDesktop 27% · Mobile 73%
Websites whose visitors overlap most with myTomorrows. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| trials4us.co.uk | 100% | – | #507,113 | View details | |
eyeforpharma.com | eyeforpharma.com | 95% | – | – | – |
| ppd.com | 94% | 226.8K | #271,623 | View details | |
| parentprojectmd.org | 76% | 55.1K | #526,697 | View details | |
| chdr.nl | 76% | 11K | #1,756,670 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for myTomorrows
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Mytomorrows
Complete news archive for myTomorrows
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to myTomorrows
10 companies that operate in the same segment as myTomorrows (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about myTomorrows
myTomorrows was founded in 2012.
myTomorrows is headquartered in Amsterdam, Netherlands.
Ronald Brus is the current CEO of myTomorrows. They have also founded this company.
myTomorrows is a funded company, having raised a total of $51.3M across 5 funding rounds to date. The company's 1st funding round was a Angel Round of $3.8M, raised on Jun 2012.
myTomorrows was established in 2012 in Amsterdam, Netherlands, within the healthcare sector. A digital platform is maintained to link patients, physicians, and pharmaceutical firms. Details on medical conditions, ongoing clinical trials, and early access initiatives are shared through the service. Applications for experimental treatments are processed, while diagnostic kits are distributed to support clinical needs.
myTomorrows's top competitors include Evidation, Dyania Health and SubjectWell.
myTomorrows has 5 investors. Key investors include Balderton Capital, EQT Ventures, Octopus Ventures, Sofinnova, and Avego.